Table 3.
Multivariate Cox proportional regression model.
| Factors | p-value | HR | 95% CI | |
|---|---|---|---|---|
| Unadjusted | ||||
| APTT | ||||
| 12-day survival analysis | <0.01 | 1.011 | 1.004 | 1.017 |
| 25-day survival analysis | 0.039 | 1.006 | 1.000 | 1.012 |
| Sepsis | ||||
| 12-day survival analysis | 0.935 | 0.978 | 0.575 | 1.664 |
| 25-day survival analysis | 0.602 | 0.881 | 0.548 | 1.417 |
| Hyperlipidemia | ||||
| 12-day survival analysis | 0.310 | 0.718 | 0.379 | 1.362 |
| 25-day survival analysis | 0.803 | 0.928 | 0.518 | 1.664 |
| Diabetes | ||||
| 12-day survival analysis | 0.142 | 1.440 | 0.885 | 2.341 |
| 25-day survival analysis | 0.816 | 1.050 | 0.697 | 1.580 |
| AKI | ||||
| 12-day survival analysis | 0.033 | 1.620 | 1.039 | 2.525 |
| 25-day survival analysis | 0.877 | 0.969 | 0.654 | 1.438 |
| Ascites | ||||
| 12-day survival analysis | 0.522 | 1.152 | 0.749 | 1.776 |
| 25-day survival analysis | 0.267 | 1.222 | 0.858 | 1.739 |
| Coagulation disorders | ||||
| 12-day survival analysis | 0.121 | 1.406 | 0.914 | 2.163 |
| 25-day survival analysis | 0.210 | 1.249 | 0.882 | 1.769 |
| Adjusted | ||||
| BUN | ||||
| 12-day survival analysis | 0.985 | 1.000 | 0.987 | 1.013 |
| 25-day survival analysis | 0.104 | 1.007 | 0.999 | 1.016 |
| Calcium | ||||
| 12-day survival analysis | 0.772 | 1.035 | 0.820 | 1.306 |
| 25-day survival analysis | 0.267 | 0.899 | 0.745 | 1.085 |
| Chloride | ||||
| 12-day survival analysis | 0.045 | 0.945 | 0.893 | 0.999 |
| 25-day survival analysis | 0.349 | 0.982 | 0.946 | 1.020 |
| Creatinine | ||||
| 12-day survival analysis | 0.498 | 1.071 | 0.879 | 1.305 |
| 25-day survival analysis | 0.468 | 0.946 | 0.814 | 1.099 |
| Sodium | ||||
| 12-day survival analysis | 0.083 | 1.063 | 0.992 | 1.139 |
| 25-day survival analysis | 0.439 | 1.021 | 0.968 | 1.077 |
| WBC | ||||
| 12-day survival analysis | 0.004 | 1.059 | 1.018 | 1.102 |
| 25-day survival analysis | 0.231 | 1.014 | 0.991 | 1.037 |
| MCH | ||||
| 12-day survival analysis | 0.236 | 1.798 | 0.682 | 4.743 |
| 25-day survival analysis | 0.141 | 1.862 | 0.814 | 4.259 |
| MCHC | ||||
| 12-day survival analysis | 0.229 | 0.559 | 0.217 | 1.441 |
| 25-day survival analysis | 0.141 | 0.529 | 0.227 | 1.235 |
| APTT | ||||
| 12-day survival analysis | 0.033 | 1.012 | 1.001 | 1.022 |
| 25-day survival analysis | 0.013 | 1.010 | 1.002 | 1.018 |
| Sepsis | ||||
| 12-day survival analysis | 0.408 | 0.772 | 0.418 | 1.425 |
| 25-day survival analysis | 0.546 | 0.851 | 0.504 | 1.437 |
| Hyperlipidemia | ||||
| 12-day survival analysis | 0.584 | 0.804 | 0.369 | 1.753 |
| 25-day survival analysis | 0.764 | 1.108 | 0.567 | 2.168 |
| Diabetes | ||||
| 12-day survival analysis | 0.071 | 1.696 | 0.955 | 3.010 |
| 25-day survival analysis | 0.452 | 1.220 | 0.726 | 2.051 |
| AKI | ||||
| 12-day survival analysis | 0.977 | 1.008 | 0.573 | 1.775 |
| 25-day survival analysis | 0.376 | 0.804 | 0.497 | 1.302 |
| Ascites | ||||
| 12-day survival analysis | 0.805 | 1.065 | 0.647 | 1.752 |
| 25-day survival analysis | 0.711 | 1.088 | 0.697 | 1.697 |
| Coagulation disorders | ||||
| 12-day survival analysis | 0.523 | 0.835 | 0.480 | 1.453 |
| 25-day survival analysis | 0.160 | 1.383 | 0.879 | 2.176 |
| Isoprenaline | ||||
| 12-day survival analysis | 0.093 | 1.736 | 0.913 | 3.303 |
| 25-day survival analysis | 0.015 | 1.921 | 1.137 | 3.246 |
| Gender | ||||
| 12-day survival analysis | 0.172 | 1.492 | 0.841 | 2.650 |
| 25-day survival analysis | 0.475 | 1.176 | 0.754 | 1.834 |
| Age | ||||
| 12-day survival analysis | 0.115 | 1.016 | 0.996 | 1.037 |
| 25-day survival analysis | 0.285 | 1.010 | 0.992 | 1.029 |
CIs, confidence intervals; HRs, hazard ratios; BUN, urea nitrogen; WBC, white blood cell count; MCHC, mean corpuscular-hemoglobin concentration; AKI, acute kidney injury; APTT, activated partial thromboplastin time; MCH, mean corpuscular hemoglobin. Multivariate Cox proportional regression model was used to calculate HRs with 95% CIs. Model 1 was unadjusted. Model 2 was adjusted for age, gender, use of isoprenaline, patient’s past medical history of diabetes, sepsis, ascites, coagulation disorders, and other laboratory tests.The values marked in bold indicate that the p-values are less than 0.05, which means they are statistically significant.